Morepen Laboratories Shares Plummet 5% as Q4 Earnings Decline 48% QoQ; Announces 10% Final Dividend
Synopsis: Morepen Laboratories Ltd reported a mixed Q4 FY26 performance with stable revenue growth but pressure on profitability and margins. The company also announced a final dividend of Rs. 0.20 per equity share for FY26. Despite steady sales growth, lower operating margins and higher tax expenses impacted the company's bottom-line performance during the quarter. Morepen Laboratories Ltd is a pharmaceutical…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
